Physician profile
Alysa Ann James
NPI 1548610116
$1,432.71
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $455 · 2021: $440 · 2022: $269 · 2023: $64.95 · 2024: $44.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $64.95 · Food and Beverage: $44.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $64.95 |
| Food and Beverage | $44.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $192.76 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $159.39 | 2020-2021 | |
| Novo Nordisk INC | $155.78 | 2020-2022 | |
| Glaxosmithkline, LLC. | $110.73 | 2022 | |
| Allergan, INC. | $102.26 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $100.43 | 2020-2021 | |
| Astellas Pharma US INC | $95.50 | 2023-2024 | Veozah |
| Axonics, INC. | $78.90 | 2021 | |
| Merck Sharp & Dohme LLC | $75.88 | 2020-2021 | |
| Vifor Pharma, INC. | $71.35 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $69.44 | 2020-2021 | |
| Edwards Lifesciences Corporation | $34.22 | 2019-2021 | |
| Abbvie INC. | $33.77 | 2021 | |
| Alexion Pharmaceuticals, INC. | $31.89 | 2019-2020 | |
| Pfizer INC. | $27.91 | 2021-2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $24.87 | 2019 | |
| Melinta Therapeutics, LLC | $18.67 | 2021 | |
| Bausch Health US, LLC | $14.80 | 2022 | |
| Tetraphase Pharmaceuticals, INC. | $13.00 | 2019 | |
| Gilead Sciences, INC. | $11.05 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alysa James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.